Don’t market stem-cell products ahead of proof
Wednesday, July 17, 2013 - 10:30
in Health & Medicine
The controversy over an unproven stem-cell therapy in Italy highlights the dangers of doing translational medicine in reverse, argues Paolo Bianco.Nature 499 255 doi: 10.1038/499255a